Hanson & Doremus Investment Management’s Allergan plc AGN Stock Holding History

Hanson & Doremus Investment Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-141	Closed	-$27K	–	469
2018 Q3	$27K	Hold	141	–	–	0.01%	337
2018 Q2	$24K	Hold	141	–	–	0.01%	361
2018 Q1	$24K	Hold	141	–	–	0.01%	381
2017 Q4	$23K	Hold	141	–	–	0.01%	379
2017 Q3	$29K	Hold	141	–	–	0.01%	340
2017 Q2	$34K	Hold	141	–	–	0.01%	317
2017 Q1	$34K	Hold	141	–	–	0.01%	298
2016 Q4	$29.6K	Hold	141	–	–	0.01%	301
2016 Q3	$32K	Buy	141 +60	+74%	+$14.7K	0.01%	278
2016 Q2	$19K	Buy	81 +27	+50%	+$6.22K	0.01%	316
2016 Q1	$10K	Buy	+54	New	+$15.5K	﹤0.01%	382

Other funds holding AGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Hanson & Doremus Investment Management's AGN Position: Q4 2018 in Review

Hanson & Doremus Investment Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 141 shares — an estimated $27K sold.

Hanson & Doremus Investment Management first reported a position in AGN in Q1 2016 and held it in 11 quarters. The position peaked at $34K in Q2 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

Hanson & Doremus Investment Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
Hanson & Doremus Investment Management sold 141 Allergan plc shares in Q4 2018, an estimated $27K.
Hanson & Doremus Investment Management first reported a position in Allergan plc in Q1 2016 and held it in 11 quarters.
Hanson & Doremus Investment Management's Allergan plc position peaked at $34K in Q2 2017.
1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Hanson & Doremus Investment Management's 13F filing for Q4 2018, filed 31 Jan 2019.